World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
80
Citations
26358
World Ranking
1148
National Ranking
520

Medicine

D-Index
80
Citations
26897
World Ranking
17002
National Ranking
8526

Overview

Scott Letendre is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medical and immunological aspects related to infectious diseases, with a significant emphasis on HIV research and treatment. Their work spans various subfields including virology, infectious diseases, emergency medicine, biological psychiatry, and neurology.

The scientist has contributed extensively to topics such as HIV research and treatment, HIV-related health complications and treatments, HIV/AIDS research and interventions, tryptophan and brain disorders, neuroinflammation and neurodegeneration mechanisms, cannabis and cannabinoid research, and pharmacological effects and toxicity studies.

Recent publications by Scott Letendre include:

  • Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood, 2020, Neurology Neuroimmunology & Neuroinflammation
  • Antiretroviral drug concentrations in brain tissue of adult decedents, 2020, AIDS
  • Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV, 2021, Journal of the International Neuropsychological Society
  • Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study, 2022, Brain
  • Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior, 2020, Journal of Neuroimmune Pharmacology

Frequent coauthors of Scott Letendre include Ronald J. Ellis, Jennifer E. Iudicello, Igor Grant, Robert K. Heaton, and Donald Franklin.

The scientist regularly publishes in journals such as Viruses, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of NeuroVirology, and UNC Libraries.

Best Publications

  • HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

    R. K. Heaton;D. B. Clifford;D. R. Franklin;S. P. Woods

  • HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

    Robert K. Heaton;Donald R. Franklin;Ronald J. Ellis;J. Allen McCutchan

  • Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

    Scott Letendre;Jennifer Marquie-Beck;Edmund Capparelli;Brookie Best

  • CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.

    Ronald J. Ellis;Jayraan Badiee;Florin Vaida;Scott Letendre

  • Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study

    Robert K. Heaton;Donald R. Franklin;Reena Deutsch;Scott Letendre

  • Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

    Christina M. Marra;Yu Zhao;David B. Clifford;Scott Letendre

  • Soluble CD163 Made by Monocyte/Macrophages Is a Novel Marker of HIV Activity in Early and Chronic Infection Prior to and After Anti-retroviral Therapy

    Tricia H. Burdo;Margaret R. Lentz;Patrick Autissier;Anitha Krishnan

  • Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

    Igor Grant;Donald R. Franklin;Reena Deutsch;Steven P. Woods

  • Correction: Corrigendum: Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART

    Michelli Faria de Oliveira;Ben Murrell;Josué Pérez-Santiago;Milenka Vargas

  • Co-Morbidities in Persons Infected with HIV: Increased Burden with Older Age and Negative Effects on Health-Related Quality of Life

    Alan T Rodriguez-Penney;Jennifer E Iudicello;Patricia K Riggs;Katie Doyle

  • Controversies in HIV-associated neurocognitive disorders

    Sam Nightingale;Alan Winston;Scott Letendre;Benedict D Michael;Benedict D Michael

  • Neurologic complications of HIV disease and their treatment.

    Scott Letendre;Beau Ances;Sarah Gibson;Ronald J Ellis

  • Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.

    Tricia H. Burdo;Allison Weiffenbach;Steven P. Woods;Scott Letendre

  • Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

    Scott L Letendre;J Allen McCutchan;Meredith E Childers;Steven P Woods

  • Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.

    Marlene Smurzynski;Kunling Wu;Scott Letendre;Kevin Robertson

  • Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy.

    Ronald J. Ellis;Meredith E. Childers;Mariana Cherner;Deborah Lazzaretto

  • Pathogenesis of HIV in the Central Nervous System

    Victor Valcour;Pasiri Sithinamsuwan;Scott Letendre;Beau Ances

  • Changing patterns in the neuropathogenesis of HIV during the HAART era.

    T. D. Langford;S. L. Letendre;G. J. Larrea;E. Masliah

  • Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder.

    Scott Letendre

  • Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.

    I. Everall;F. Vaida;N. Khanlou;D. Lazzaretto

Frequent Co-Authors

Ronald J. Ellis
Ronald J. Ellis University of California, San Diego
Igor Grant
Igor Grant University of California, San Diego
Robert K. Heaton
Robert K. Heaton University of California, San Diego
Donald Franklin
Donald Franklin University of California, San Diego
J. Allen McCutchan
J. Allen McCutchan University of California, San Diego
David B. Clifford
David B. Clifford Washington University in St. Louis
Steven Paul Woods
Steven Paul Woods University of Houston
Benjamin B. Gelman
Benjamin B. Gelman The University of Texas Medical Branch at Galveston
Susan Morgello
Susan Morgello Icahn School of Medicine at Mount Sinai
Davey M. Smith
Davey M. Smith University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to diverse career opportunities, both in traditional labs and expanding healthcare roles. Many students explore related online degrees to enhance their expertise and improve job prospects. For example, those interested in holistic health might consider pathways like Functional Medicine Nurse Practitioner programs, which often highlight the functional medicine NP salary to assess potential earnings.

For individuals with unique challenges, including those with criminal records, the availability of college degrees for felons allows for fresh starts in fields related to microbiology and healthcare. Such opportunities emphasize the importance of accessible education and career adaptability.

In medical coding and healthcare administration, online programs prepare students for certifications like becoming a Certified Professional Coder, where knowing the certified professional coder salary can guide career decisions. Additionally, career paths like becoming a Child Life Specialist appeal to those who want to combine healthcare knowledge with patient interaction, making it useful to research how much do child life specialists make when planning this route.

Exploring these related degrees and career pathways allows microbiology students to diversify skills, target growth industries, and optimize their educational investments for future success.

Best Scientists Citing Scott Letendre

Trending Scientists